Objective. Increasing evidences suggest that thyroid metabolism has a major role on the prognosis of cardiac patients. Cardiac surgery is a well recognized cause of thyroid dysfunction. This study evaluates the role of thyroid profile evaluation in the preoperative assessment of cardiac surgery patients. Methods. Free triiodothyronine (fT3), free thiroxine (fT4) and thyroid stimulating hormone (TSH) were assayed in 107 consecutive patients undergoing coronary artery bypass grafting (CABG) by the AxSYM (Abbott Laboratories, Diagnostic Division, Abbott Park, USA) Microparticle Enzyme Immunoassay (MEIA); serum samples, collected in serum separator tubes, were immediately centrifuged and stored at -20°C till the analysis was performed. All the samples from the same patient were analyzed together in the same session in order to minimize the inter-assays variations. Results. A strong correlation was found between low fT3 concentration at admission and postoperative atrial fibrillation (AF), that occurred in 33 (30.8%) patients. An older age (p=0.03), no therapy with β-blockers (p=0.08), chronic obstructive pulmonary disease (p=0.08), lower left ventricle ejection fraction (p=0.09), and lower fT3 concentration (p=0.001) were all univariate predictors of postoperative AF. On multivariate analysis, low fT3 resulted to be the most important independent predictor of postoperative AF (OR 4.425; 95% CI, 1.745-11.235; p=0.001). Conclusions. Our data show the existence of a strong, previously unrecognized, relationship between low fT3 at admission and AF after CABG. These finding remarks the importance of thyroid profile laboratory evaluation in patients undergoing CABG, in order to reduce postoperative AF risk. comunicazioni orali
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Results: Overall, we identified 8 MYPC3 mutations in 7 patients (a 12% prevalence). Six mutations were novel (IVS18+1C>T, insT753, A522T, V771M, E165D, R1241L), and not detectable in 100 normal controls, thus excluding the possibility of polymorphisms; two (A522T and V771M) were found in eterozigosity in the same patient. The remaining two mutations have been previously reported (Q969X, IVS23+1A >G). Average age at diagnosis in the 7 patients was 40.1±13.6; echocardiographic features and outcome were variable. Six of the eight patients had a benign outcome and family history; one (E165D, male, age 42), is currently in NYHA functional class III due to end stage progression of the disease; and one (IVS18+1C>T, female, age 54) had severe functional limitation. Conclusions: In a regional HCM population from Italy, MYBPC3 mutations were common and were associated with a broad spectrum of clinical and echocardiographic manifestations. Most of the mutations had not been previously described, including 2 occurring in the same patient.
